Venus Concept Inc logo

VERO - Venus Concept Inc News Story

$1.48 -0.1  -3.9%

Last Trade - 26/01/22

Sector
Healthcare
Size
Small Cap
Market Cap £61.8m
Enterprise Value £108.3m
Revenue £73.2m
Position in Universe 5577th / 7412

Venus Concept Inc. to Participate in the Stifel 2021 Virtual Healthcare Conference

Wed 10th November, 2021 9:05pm
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211110:nGNX5LY2yv&default-theme=true


TORONTO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus
Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic
technology leader, today announced that management will participate in the
Stifel 2021 Virtual Healthcare Conference.

Management will participate in a fireside chat at the conference on Wednesday,
November 17th at 4:00 p.m. Eastern Time.

An audio webcast of the presentation will be accessible under the “Events”
section of the Company's investor relations website at
https://ir.venusconcept.com/. An archive of the webcast will be available for
replay following the conference.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with
a broad product portfolio of minimally invasive and non-invasive medical
aesthetic and hair restoration technologies and reach in over 60 countries and
18 direct markets. Venus Concept focuses its product sales strategy on a
subscription-based business model in North America and in its well-established
direct global markets. Venus Concept’s product portfolio consists of
aesthetic device platforms, including Venus Versa, Venus Legacy, Venus
Velocity, Venus Fiore, Venus Freedom, Venus Viva, Venus Freeze Plus, Venus
Glow, Venus Bliss, Venus Epileve and Venus Viva MD. Venus Concept’s hair
restoration systems include NeoGraft®, an automated hair restoration system
that facilitates the harvesting of follicles during a FUE process and the
ARTAS® and ARTAS iX® Robotic Hair Restoration systems, which harvest
follicular units directly from the scalp and create recipient implant sites
using proprietary algorithms. Venus Concept has been backed by leading
healthcare industry growth equity investors including EW Healthcare Partners
(formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management,
and Aperture Venture Partners.


Investor Relations Contact:
ICR Westwicke on behalf of Venus Concept: 
Mike Piccinino, CFA
VenusConceptIR@westwicke.com


(https://www.globenewswire.com/NewsRoom/AttachmentNg/81cf55e5-d665-4ddf-8011-51412960a3a6)



GlobeNewswire, Inc. 2021
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.